Psychiatry · Lincoln, NE
NPI
1093853368
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8101 O St, Suite 300
Lincoln, NE, 68510
Phone (402) 476-6060
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
2,828 services
Medicare patients, 2024
292
Average age 64
Drug cost, 2024
$2.2M
11,054 prescriptions
Company payments, 2025
$2,369
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walter J Duffy was code 99214 (office e&m - established), 1,410 times for 270 patients. In total Walter J Duffy billed 2,828 services in 22 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,410 | 270 | $79.96 | $113K |
| 90868 Treatment - Miscellaneous | Office | 791 | 24 | $99.52 | $79K |
| 90869 Treatment - Miscellaneous | Office | 160 | 24 | $100.11 | $16K |
| 96372 Injection Administration | Office | 86 | 13 | $8.42 | $724 |
| 99215 Office E&M - Established | Office | 68 | 46 | $115.02 | $7,821 |
| 92552 Vision, Hearing, and Speech Services | Office | 49 | 24 | $22.16 | $1,086 |
| 90837 Psychotherapy - Nongroup | Office | 46 | 11 | $70.94 | $3,263 |
| 99406 Behavioral Health Services | Office | 45 | 27 | $12.17 | $548 |
| 90792 Psychotherapy - Nongroup | Office | 38 | 38 | $128.76 | $4,893 |
| 90833 Psychotherapy - Nongroup | Office | 33 | 27 | $46.42 | $1,532 |
| 90867 Treatment - Miscellaneous | Office | 32 | 24 | $120.76 | $3,864 |
| 99205 Office E&M - New | Office | 22 | 22 | $133.26 | $2,932 |
By year: 2022 $262K for 3,472 services; 2023 $206K for 2,744 services; 2024 $236K for 2,828 services.
Medicare prescription drug claims, 2024
In 2024, the drug Walter J Duffy prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 525 prescriptions and refills. In total Walter J Duffy wrote 11,054 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bupropion Xl Bupropion Hcl | 525 | 633 | 69 | $8,683 |
| Lorazepam Generic | 492 | 500 | 70 | $4,215 |
| Quetiapine Fumarate Generic | 451 | 513 | 67 | $8,179 |
| Alprazolam Generic | 442 | 459 | 77 | $2,962 |
| Lamotrigine Generic | 420 | 543 | 70 | $4,774 |
| Duloxetine Hcl Generic | 419 | 541 | 71 | $8,680 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 387 | 481 | 53 | $17K |
| Buspirone Hcl Generic | 383 | 477 | 72 | $7,163 |
| Trazodone Hcl Generic | 319 | 379 | 64 | $3,786 |
| Clonazepam Generic | 318 | 333 | 58 | $3,751 |
| Aripiprazole Generic | 301 | 338 | 57 | $15K |
| Mirtazapine Generic | 272 | 379 | 64 | $3,270 |
| Olanzapine Generic | 265 | 293 | 31 | $6,126 |
| Methylphenidate Hcl Generic | 260 | 260 | 43 | $5,581 |
| Escitalopram Oxalate Generic | 250 | 309 | 43 | $3,430 |
Brand drugs: 1,150 claims; generic drugs: 9,904 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walter J Duffy $2,369 ($2,369 in general payments such as food, travel and fees) from 21 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $445.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 26 | $445 |
| Jazz Pharmaceuticals Inc. JAZZ | 15 | $342 |
| Alkermes, Inc. ALKS | 34 | $303 |
| Axsome Therapeutics, Inc. AXSM | 30 | $298 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 18 | $291 |
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $219 |
| Janssen Pharmaceuticals, Inc JNJ | 5 | $82.31 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $70.9 |
| Biogen, Inc. BIIB | 3 | $63.77 |
| Corium, LLC | 2 | $57.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.